D. Falzarano

Robert J. Fischer, T. Nyenswah, J. Strong, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.

J. Strong, A. Takada, H. Ebihara, 2011, The Journal of infectious diseases.

Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections.

H. Feldmann, D. Falzarano, A. Marzi, 2011, Journal of bioterrorism & biodefense.

Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome

H. Feldmann, D. Falzarano, D. Safronetz, 2013, Antimicrobial Agents and Chemotherapy.

Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells

J. Julien, E. Rujas, Shelby Landreth, 2022, bioRxiv.

Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model

D. Falzarano, Guodong Liu, D. Safronetz, 2021, Scientific Reports.

Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets

D. Dimitrov, H. Feldmann, T. Ying, 2017, Antiviral Research.

Ebola sGP—The first viral glycoprotein shown to be C-mannosylated

H. Feldmann, G. Van Domselaar, O. Krokhin, 2007, Virology.

Immune Responses to MERS-CoV in Humans and Animals.

D. Falzarano, N. Alharbi, Swarali S. Kulkarni, 2021, Advances in experimental medicine and biology.

A synthetic consensus anti-Spike protein DNA vaccine induces protective immunity against Middle East Respiratory Syndrome Coronavirus in non-human primates

N. Sardesai, G. Kobinger, H. Feldmann, 2016, International Journal of Infectious Diseases.

A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

N. Sardesai, J. Kim, D. Weiner, 2015, Science Translational Medicine.

Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques

H. Feldmann, D. Falzarano, V. Munster, 2018, Front. Immunol..

An Acute Immune Response to Middle East Respiratory Syndrome Coronavirus Replication Contributes to Viral Pathogenicity

H. Feldmann, D. Falzarano, V. Munster, 2016, The American Journal of Pathology.

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

Michael G. Katze, Heinz Feldmann, Atsushi Okumura, 2013, Proceedings of the National Academy of Sciences.

Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model

H. Feldmann, S. Perlman, D. Falzarano, 2016, Virus Research.

Foodborne Transmission of Nipah Virus in Syrian Hamsters

H. Feldmann, D. Falzarano, V. Munster, 2014, PLoS pathogens.

Possible leap ahead in filovirus therapeutics

H. Feldmann, D. Falzarano, 2014, Cell Research.

Vaccines for viral hemorrhagic fevers--progress and shortcomings.

H. Feldmann, D. Falzarano, 2013, Current opinion in virology.

Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs.

G. Kobinger, D. Falzarano, H. Weingartl, 2011, The Journal of infectious diseases.

A Syrian golden hamster model recapitulating ebola hemorrhagic fever.

Y. Kawaoka, H. Ebihara, H. Feldmann, 2013, The Journal of infectious diseases.

Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral Compounds.

D. Falzarano, 2017, Methods in molecular biology.

Clinical Chemistry of Patients With Ebola in Monrovia, Liberia.

Robert J. Fischer, T. Nyenswah, H. Ebihara, 2016, The Journal of infectious diseases.

The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak

Robert J. Fischer, T. Nyenswah, J. Strong, 2016, Emerging infectious diseases.

Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody Responses.

H. Feldmann, D. Falzarano, Joseph B. Prescott, 2015, The Journal of infectious diseases.

Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.

H. Ebihara, D. Falzarano, L. Banadyga, 2016, The Journal of infectious diseases.

53 – Arenaviruses and filoviruses: Viral haemorrhagic fevers

H. Feldmann, D. Falzarano, D. Safronetz, 2012 .

Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters

H. Fausther-Bovendo, G. Kobinger, S. Gray-Owen, 2022, NPJ vaccines.

Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection

M. Frieman, D. Falzarano, R. Haupt, 2022, Scientific Reports.

Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions

Shan Ying, E. Pringle, Brett A. Duguay, 2022, bioRxiv.

Correction to: Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model

J. Strong, X. Qiu, G. Wong, 2019, Intensive Care Medicine Experimental.

Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model

J. Strong, X. Qiu, A. Bello, 2019, Intensive Care Medicine Experimental.

SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia

D. Falzarano, A. Banerjee, G. Evans, 2022, Redox Biology.

SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse Model

D. Falzarano, Steven Machtaler, Yunyun Di, 2022, Viruses.

Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus Infection

Lijuan Yuan, D. Falzarano, Kyle D Brumfield, 2022, Viruses.

High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection

A. Kusalik, V. Gerdts, D. Falzarano, 2022, Scientific Reports.

Ebola vaccines: we have options.

D. Falzarano, 2016, The Lancet. Infectious diseases.

Animal models for COVID-19

Lisa E. Gralinski, J. Chan, J. Segalés, 2020, Nature.

Unique aspects of adaptive immunity in camelids and their applications.

D. Falzarano, Swarali S. Kulkarni, 2021, Molecular immunology.

Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells

F. Vizeacoumar, Kalpana K Bhanumathy, D. Falzarano, 2021, Pathogens.

Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection

B. Sitek, M. Eisenacher, T. Pietschmann, 2022, Proceedings of the National Academy of Sciences.

SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney

V. Gerdts, D. Falzarano, A. Kroeker, 2021, bioRxiv.

Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike Antigen

M. Cygler, Olivier Fisette, Shelby Landreth, 2021, Journal of Molecular Biology.

Viral haemorrhagic fever and vascular alterations.

H. Feldmann, D. Falzarano, H. Schnittler, 2008, Hamostaseologie.

Ebola virus: unravelling pathogenesis to combat a deadly disease.

Thomas Hoenen, Heinz Feldmann, H. Feldmann, 2006, Trends in molecular medicine.

Interferon Regulatory Factor 3-Mediated Signaling Limits Middle-East Respiratory Syndrome (MERS) Coronavirus Propagation in Cells from an Insectivorous Bat

V. Misra, D. Falzarano, A. Banerjee, 2019, Viruses.

Ebola Virus RNA Editing Depends on the Primary Editing Site Sequence and an Upstream Secondary Structure

H. Ebihara, H. Feldmann, S. Ricklefs, 2013, PLoS pathogens.

A New Ebola Virus Nonstructural Glycoprotein Expressed through RNA Editing

Heinz Feldmann, Jochen Seebach, H. Feldmann, 2011, Journal of Virology.

Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care Environment

J. Strong, X. Qiu, G. Wong, 2021, Microorganisms.

Animal models for COVID-19

Lisa E. Gralinski, J. Chan, J. Segalés, 2020, Nature.

The Ebola virus soluble glycoprotein (sGP) does not affect lymphocyte apoptosis and adhesion to activated endothelium.

H. Feldmann, D. Falzarano, H. Schnittler, 2011, The Journal of infectious diseases.

2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness.

S. Rubino, M. Al-Ahdal, D. Kelvin, 2020, Journal of infection in developing countries.

An updated Ebola vaccine: immunogenic, but will it protect?

D. Falzarano, A. Marzi, 2015, The Lancet.

Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants

A. Gingras, J. Wrana, K. Colwill, 2022, bioRxiv.

Spike protein disulfide disruption as a potential treatment for SARS-CoV-2

M. Cygler, D. Falzarano, G. George, 2021, bioRxiv.

Disulfide Bonds Play a Critical Role in the Structure and Function of the SARS-CoV-2 Spike Antigen

M. Cygler, Olivier Fisette, Shelby Landreth, 2022 .

Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study

S. Rubino, K. Rockwood, M. Andrew, 2021, EClinicalMedicine.

Selection of viral variants during persistent infection of insectivorous bat cells with Middle East respiratory syndrome coronavirus

V. Misra, D. Falzarano, A. Banerjee, 2020, Scientific Reports.

Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets

M. Cameron, V. Gerdts, D. Falzarano, 2021, Scientific Reports.

Regulation of endothelial barrier function during flow-induced conversion to an arterial phenotype.

Gerald Donnert, Jochen Seebach, Stefan W Hell, 2007, Cardiovascular research.

Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced Cytopathology

F. Vizeacoumar, Arunandan Kumar, D. Falzarano, 2023, bioRxiv.

Longitudinal analysis of SARS-CoV-2 reinfection reveals distinct kinetics and emergence of cross-neutralizing antibodies to variants of concern

V. Gerdts, D. Falzarano, A. Kroeker, 2023, Frontiers in Microbiology.

Development and application of reporter-expressing mononegaviruses: current challenges and perspectives.

D. Falzarano, T. Hoenen, A. Groseth, 2014, Antiviral research.

Male sex and age biases viral burden, viral shedding, and type 1 and 2 interferon responses during SARS-CoV-2 infection in ferrets

M. Cameron, V. Gerdts, C. Richardson, 2021, bioRxiv.

Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response.

C. Richardson, D. Falzarano, R. Brownlie, 2021, Journal of infection in developing countries.

The influenza universe in an mRNA vaccine

D. Falzarano, A. Kelvin, 2022, Science.

Selection of viral variants during persistent infection of insectivorous bat cells with Middle East respiratory syndrome coronavirus

V. Misra, D. Falzarano, A. Banerjee, 2020, Scientific Reports.

The RNA Interference Effector Protein Argonaute 2 Functions as a Restriction Factor Against SARS-CoV-2

J. Pelletier, Joaquin Lopez-Orozco, T. Hobman, 2023, Journal of molecular biology.

Dromedary camels in northern Mali have high seropositivity to MERS-CoV

H. Feldmann, Jacqueline Cronin, D. Falzarano, 2017, One Health.

Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamsters

H. Fausther-Bovendo, G. Kobinger, S. Gray-Owen, 2022, npj Vaccines.

Coronavirus Pandemic Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response

C. Richardson, D. Falzarano, R. Brownlie, 2021 .

N-Phenylpyridine-3-Carboxamide and 6-Acetyl-1H-Indazole Inhibit the RNA Replication Step of the Dengue Virus Life Cycle

Simon S. Woo, R. Bartenschlager, S. LaPlante, 2023, Antimicrobial agents and chemotherapy.

Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals

Davide Marnetto, F. Montinaro, T. Capellini, 2021, bioRxiv.

Delineating Ebola entry

H. Feldmann, D. Falzarano, 2015, Science.

The Ebola virus soluble glycoprotein (sGP) does not affect lymphocyte apoptosis and adhesion to activated endothelium.

H. Feldmann, D. Falzarano, H. Schnittler, 2011, The Journal of infectious diseases.

Development and application of reporter-expressing mononegaviruses: current challenges and perspectives.

D. Falzarano, T. Hoenen, A. Groseth, 2014, Antiviral research.

A phenothiazine urea derivative broadly inhibits coronavirus replication via viral protease inhibition.

Brett A. Duguay, D. Falzarano, C. McCormick, 2023, Antiviral research.